Amivantamab in non-small-cell lung cancer

Amivantamab in non-small-cell lung cancer

Bibliographic Details
Main Author:	Harsh Sahu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Cancer Research, Statistics, and Treatment
Online Access:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2023;volume=6;issue=3;spage=486;epage=487;aulast=Sahu

Similar Items

The development of amivantamab for the treatment of non-small cell lung cancer
by: Danielle Brazel, et al.
Published: (2023-10-01)

Amivantamab: A narrative drug review
by: Anupa John, et al.
Published: (2023-01-01)

Severe scalp ulcerations and granulomata during treatment with amivantamab
by: Jingjia J Zhou, et al.
Published: (2024-03-01)

Mobocertinib and Bevacizumab for Amivantamab-Refractory Lung Cancer With EGFR Exon 20 Insertion Mutation: A Case Report
by: Jaemin Kim, BS, et al.
Published: (2023-12-01)

Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations
by: Petrini I, et al.
Published: (2022-10-01)

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?
by: Brazel D, et al.
Published: (2024-04-01)

Amivantamab: Is it really a game changer for EGFR exon 20 insertion mutation?
by: Darshit K Shah
Published: (2023-01-01)

Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
by: Pridhvi Krishna Gaddey, et al.
Published: (2024-04-01)

Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
by: Zaid Sirhan, et al.
Published: (2023-08-01)

Cost-effectiveness analysis of amivantamab plus chemotherapy versus chemotherapy alone in NSCLC with EGFR Exon 20 insertions
by: Ping Yue, et al.
Published: (2024-03-01)

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.
by: Shawn J Rice, et al.
Published: (2021-01-01)

Oligoprogression in Non-Small Cell Lung Cancer
by: Daijiro Harada, et al.
Published: (2021-11-01)

Angiogenesis and Non Small Cell Lung Cancer
by: Metodieva S
Published: (2008-01-01)

Non‐small cell lung cancer in China
by: Peixin Chen, et al.
Published: (2022-10-01)

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
by: Isa Mambetsariev, et al.
Published: (2022-03-01)

Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer
by: Frank Aboubakar Nana, et al.
Published: (2019-10-01)

Amivantamab, the first epidermal growth factor receptor and mesenchymal–epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia
by: Karina J. Cancel-Artau, MD, et al.
Published: (2024-03-01)

Exploration of lung mycobiome in the patients with non-small-cell lung cancer
by: Yiming Zhao, et al.
Published: (2023-03-01)

Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
by: Mark Kriegsmann, et al.
Published: (2020-06-01)

Cellular Senescence in Non-Small Cell Lung Cancer
by: Huangkai Zhu, et al.
Published: (2023-12-01)

Mechanisms of Resistance in Non-Small Cell Lung Cancer
by: Alexandra-Maria HOZA, et al.
Published: (2023-12-01)

Non-Small Cell Lung Cancer—Tumor Biology
by: Mumtaz V. Rojiani, et al.
Published: (2024-02-01)

The Purinergic Landscape of Non-Small Cell Lung Cancer
by: Serena Janho dit Hreich, et al.
Published: (2022-04-01)

Visceral Obesity in Non-Small Cell Lung Cancer
by: Lindsay Nitsche, et al.
Published: (2022-07-01)

Notch Transduction in Non-Small Cell Lung Cancer
by: Amnah Sharif, et al.
Published: (2020-08-01)

Aptamers in Non-Small Cell Lung Cancer Treatment
by: Irena Wieleba, et al.
Published: (2020-07-01)

LncRNAs in Non-Small-Cell Lung Cancer
by: Lucy Ginn, et al.
Published: (2020-06-01)

Vaccine Therapy in Non-Small Cell Lung Cancer
by: Miguel García-Pardo, et al.
Published: (2022-05-01)

Classifying Oligometastatic Non-Small Cell Lung Cancer
by: Alisa N. Blumenthaler, et al.
Published: (2021-09-01)

BRAF Inhibitors in Non-Small Cell Lung Cancer
by: Vincenzo Sforza, et al.
Published: (2022-10-01)

RET Inhibitors in Non-Small-Cell Lung Cancer
by: Priscilla Cascetta, et al.
Published: (2021-09-01)

Biological insights in non-small cell lung cancer
by: Rafael Rosell, et al.
Published: (2023-07-01)

The Evolution of Therapies in Non-Small Cell Lung Cancer
by: Vishal Boolell, et al.
Published: (2015-09-01)

Editorial: Imaging in non-small cell lung cancer
by: Yiyan Liu
Published: (2023-02-01)

HYPERTHERMIA IN TREATMENT OF NON-SMALL CELL LUNG CANCER
by: А. Yu. Dobrodeev, et al.
Published: (2016-02-01)

Biomarkers for non-small cell lung cancer immunotherapy
by: D. A. Kharagezov, et al.
Published: (2021-09-01)

Microbiota Diversity in Non-Small Cell Lung Cancer Gut and Mouth Cavity Microbiota Diversity in Non-Small Cell Lung Cancer Patients
by: Brisudová Aneta, et al.
Published: (2023-12-01)

Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
by: Ding-Yu Rao, et al.
Published: (2023-04-01)

Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating <i>EGFR</i> Exon 20 Insertion Mutations
by: Petros Christopoulos, et al.
Published: (2023-11-01)

Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer
by: Satoshi Hokari, et al.
Published: (2020-02-01)